MIRA Pharmaceuticals Inc. Common Stock (MIRA)
Stock · NASDAQ · Health Care
$0.6321as of 10/16/2026
Price chart
Active signals
MIRA Signal Track Record
How signals performed across all stocks →What MIRA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 25 | -1.4% | 44% | October 1, 2026 |
| Bollinger Band Breakout | 14 | -14.0% | 21% | September 21, 2026 |
| 200-Day Moving Average TouchActive now | 9 | +11.2% | 67% | October 10, 2025 |
| Bollinger Band Breakdown | 6 | -8.0% | 33% | July 27, 2026 |
| Any 20-session window (baseline) | -4.6% | 37% |
Computed by MarketWall from daily closing prices since May 17, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MIRA
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is u…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- mirapharmaceuticals.com/
Fundamentals
- 1-day range
- $0.626$0.6791
- Market cap
- $28.50M
- P/E (trailing)
- —
- P/E (forward)
- -1.61
- EPS (trailing)
- $-0.32
- Dividend yield
- —
- Beta
- 1.66
- Avg. volume
- 593.4K
Forecasts
1 analyst ratings
MIRA Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
- GRCEGrace Therapeutics Inc. Common Stock$1.89▼ 3.08%Market cap $28.44MP/E —$1.79$5.18
- RMTIRockwell Medical Inc. Common Stock$7.43▼ 6.89%Market cap $28.26MP/E —$4.89$12.9
- KYNBKyntra Bio Inc. Common Stock$4.85▼ 9.51%Market cap $28.26MP/E 0.12$5.34$11.65
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
- ABVCABVC BioPharma Inc. Common Stock$0.918▼ 1.61%Market cap $27.09MP/E —$0.7069$3.07
- BCTXBriaCell Therapeutics Corp. Common Shares$3.4▼ 9.81%Market cap $30.01MP/E —$3.68$20.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
| GRCE Grace Therapeutics Inc. Common Stock | $28.44M | — | $1.89 | ▼ 3.08% | $1.79$5.18 |
| RMTI Rockwell Medical Inc. Common Stock | $28.26M | — | $7.43 | ▼ 6.89% | $4.89$12.9 |
| KYNB Kyntra Bio Inc. Common Stock | $28.26M | 0.12 | $4.85 | ▼ 9.51% | $5.34$11.65 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
| ABVC ABVC BioPharma Inc. Common Stock | $27.09M | — | $0.918 | ▼ 1.61% | $0.7069$3.07 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.4 | ▼ 9.81% | $3.68$20.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Thursday's session: gap up and gap down stocksChartMill · 10/1/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/21/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 9/18/2026
- MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA ReviewYahoo · 9/17/2026
- Maxim Group Initiates Coverage On Mira Pharmaceuticals with Buy Rating, Announces Price Target of $3.5Benzinga · 9/17/2026
- MIRA Pharmaceuticals Submits Phase 2a Ketamir‑2 Protocol For CIPN To IRB, Incorporating FDA Feedback And Targeting Q1 2027 Site InitiationBenzinga · 9/17/2026
- Copper Giant Identifies Thirteen Targets Beyond the Mocoa Resource and Its Interpreted ExtensionsYahoo · 9/16/2026
Insider Activity
Insider Actions →- Whalen Matthew Pratt · June 12, 2026 · Grant50.0K
- Shekhat Denil Nanji · June 12, 2026 · Grant50.0K
- MacPherson Edward Clouston · June 12, 2026 · Grant50.0K
- Del Giudice Matthew Paul · June 12, 2026 · Grant50.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 1.95M
- Total value held
- $2.09M
- Institutional holders
- 24
- Unknown693.9K
- Unknown359.4K
- Unknown290.9K
- Unknown112.3K
- Unknown90.6K
- Unknown67.7K
- Unknown60.0K
- Unknown49.1K
- Unknown37.6K
- Unknown35.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
MIRA experiences gap up/down in Thursday trading
MIRA was among the stocks that opened higher and later fell during Thursday's session, creating a gap up and gap down pattern. The move coincided with a high‑beta and volume‑spike signal, indicating increased volatility. With an RSI near 51 and support at $0.93, the price is still well above its 52‑week low. Analysts maintain a target of $3.50.
MIRA experiences gap up/down in Thursday trading. MIRA was among the stocks that opened higher and later fell during Thursday's session, creating a gap up and gap down pattern. The move coincided with a high‑beta and volume‑spike signal, indicating increased volatility. With an RSI near 51 and support at $0.93, the price is still well above its 52‑week low. Analysts maintain a target of $3.50.